Refractory Heparin-Induced Thrombocytopenia With Cerebral Venous Sinus Thrombosis Treated With IVIg, Steroids, and a Combination of Anticoagulants: A Case Report
dc.contributor.author | Gonzales, Mia | |
dc.contributor.author | Pipalia, Amrish | |
dc.contributor.author | Weil, Andrew | |
dc.date.accessioned | 2020-04-21T18:15:58Z | |
dc.date.available | 2020-04-21T18:15:58Z | |
dc.date.issued | 2019-04-02 | |
dc.description.abstract | Heparin-induced thrombocytopenia (HIT) type II is caused by antibody production that bind complexes between heparin and platelet factor 4 leading to platelet consumption and thrombosis. In a small subset of cases referred to as autoimmune HIT, the antibodies activate platelets even in the absence of heparin. Refractory HIT is a type of autoimmune HIT in which thrombocytopenia persists for weeks after heparin discontinuation and carries increased risk for thrombosis and more severe thrombocytopenia. We present a case of refractory HIT with cerebral venous sinus thrombosis (CVST) that was successfully treated with a change in anticoagulant alongside steroids and a second trial of intravenous immunoglobulin (IVIg). | en_US |
dc.identifier.doi | 10.1177/2324709619832324 | |
dc.identifier.uri | http://hdl.handle.net/10342/8296 | |
dc.subject | heparin-induced thrombocytopenia, cerebral venous sinus thrombosis, IVIg, refractory HIT, autoimmune HIT | en_US |
dc.title | Refractory Heparin-Induced Thrombocytopenia With Cerebral Venous Sinus Thrombosis Treated With IVIg, Steroids, and a Combination of Anticoagulants: A Case Report | en_US |
dc.type | Article | en_US |
ecu.journal.name | Journal of Investigative Medicine High Impact Case Reports | en_US |
ecu.journal.volume | 7 | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 2324709619832324.pdf
- Size:
- 122.79 KB
- Format:
- Adobe Portable Document Format
- Description: